Clinical Trial

A Study of Tetanus Antibody of Healthy Adults

Study acronym: tetanus
Completed
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to learn about antibody level of tetanus of adults in high-income city of china. The main question it aims to answer is: 1. Analysis of tetanus antibody distribution across different age groups 2. Evaluation of the TQS method for determining antibody status 3. Correlation between primary vaccination history and tetanus antibody concentrations Blood samples were voluntarily provided by adult healthy participants for tetanus antibody analysis over a continuous collection period of more than one year.
Trial Details
NCT Number NCT07724379
Lead Sponsor Peking University First Hospital
Conditions Tetanus
Enrollment 2,009 participants
Start Date 2025-05-04
Primary Completion 2026-03-03 (estimated)
Study Completion 2026-05-15 (estimated)
Updated on ClinicalTrials.gov 2026-07-24